Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-06 Sale | 2026-02-10 9:10 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Bruns Ingmar Chief Medical Officer | 3,297 | $2.426 | $7,998 | 33,332 (Direct) | View |
| 2026-02-06 Sale | 2026-02-10 9:10 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Vultaggio Vincent PAO and PFO | 40,224 | $2.4253 | $97,557 | 146,506 (Direct) | View |
| 2026-02-06 Sale | 2026-02-10 9:09 pm | Zentalis Pharmaceuticals Inc. | ZNTL | EASTLAND JULIA MARIE CEO & President | 8,755 | $2.426 | $21,239 | 79,133 (Direct) | View |
| 2026-02-02 Sale | 2026-02-04 8:27 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Vultaggio Vincent PAO and PFO | 3,096 | $2.5437 | $7,875 | 186,730 (Direct) | View |
| 2025-12-31 Purchase | 2026-01-08 4:57 pm | Zentalis Pharmaceuticals Inc. | ZNTL | WALTERS GROUP WALTERS WILLIAM THURMAN WALTERS SUSAN BERKLEY 10% Owner | 6,459,973 | $1.2 | $7,751,968 | 13,509,973 (Direct) | View |
| 2025-12-15 Sale | 2025-12-15 5:24 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner | 7,500,000 | $1.33 | $9,975,000 | 6,459,973 (Indirect) | View |
| 2025-04-30 Purchase | 2025-04-30 5:07 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Myers Scott Dunseth Director | 21,000 | $1.3987 | $29,373 | 281,192 (Direct) | View |
| 2025-02-06 Purchase | 2025-02-12 5:00 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Bruns Ingmar Chief Medical Officer | 20,000 | $2.2828 | $45,656 | 36,629 (Direct) | View |
| 2025-02-03 Sale | 2025-02-05 6:33 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Vultaggio Vincent PAO and Interim PFO | 2,615 | $1.7115 | $4,476 | 225,459 (Direct) | View |
| 2025-02-03 Sale | 2025-02-05 6:32 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Lackner Mark Chief Scientific Officer | 14,368 | $1.7115 | $24,591 | 637,570 (Direct) | View |
| 2025-02-03 Sale | 2025-02-05 6:31 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Paul Andrea Chief Legal Officer | 13,230 | $1.7115 | $22,643 | 1,195,498 (Direct) | View |
| 2025-01-31 Purchase | 2025-02-04 4:45 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Skvarka Jan Director | 60,000 | $1.7241 | $103,446 | 149,551 (Direct) | View |
| 2025-01-31 Purchase | 2025-02-04 4:43 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Walker Luke Nathaniel Director | 14,200 | $1.7582 | $24,966 | 86,681 (Direct) | View |
| 2025-01-31 Purchase | 2025-02-04 4:37 pm | Zentalis Pharmaceuticals Inc. | ZNTL | EASTLAND JULIA MARIE CEO & President | 28,500 | $1.7314 | $49,345 | 28,500 (Direct) | View |
| 2025-01-02 Sale | 2025-01-03 5:17 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Lackner Mark Chief Scientific Officer | 4,411 | $3.12 | $13,762 | 191,317 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-16 Option Award | 2026-06-18 4:09 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Johnson David Michael Director | 57,100 | $0 | 307,521 (Direct) | View |
| 2026-06-16 Option Award | 2026-06-18 4:08 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Skvarka Jan Director | 57,100 | $0 | 264,254 (Direct) | View |
| 2026-06-16 Option Award | 2026-06-18 4:07 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Walker Luke Nathaniel Director | 57,100 | $0 | 201,384 (Direct) | View |
| 2026-06-16 Option Award | 2026-06-18 4:07 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Kariuki Enoch Director | 57,100 | $0 | 194,465 (Direct) | View |
| 2026-06-16 Option Award | 2026-06-18 4:06 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Myers Scott Dunseth Director | 57,100 | $0 | 395,895 (Direct) | View |
| 2026-05-26 Option Award | 2026-05-27 4:11 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Campbell Shannon Director | 114,200 | $0 | 114,200 (Direct) | View |
| 2026-01-08 Option Award | 2026-01-09 8:36 pm | N/A 2036-01-07 | Zentalis Pharmaceuticals Inc. | ZNTL | Vultaggio Vincent PAO and PFO | 100,000 | $0 | 100,000 (Direct) | View |
| 2026-01-08 Option Award | 2026-01-09 8:35 pm | N/A 2036-01-07 | Zentalis Pharmaceuticals Inc. | ZNTL | Bucher James B Chief Legal Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2026-01-08 Option Award | 2026-01-09 8:34 pm | N/A 2036-01-07 | Zentalis Pharmaceuticals Inc. | ZNTL | Bruns Ingmar Chief Medical Officer | 365,000 | $0 | 365,000 (Direct) | View |
| 2026-01-08 Option Award | 2026-01-09 8:33 pm | N/A 2036-01-07 | Zentalis Pharmaceuticals Inc. | ZNTL | EASTLAND JULIA MARIE CEO & President | 775,000 | $0 | 775,000 (Direct) | View |
Ownership | 2026-01-08 4:56 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | WALTERS GROUP WALTERS WILLIAM THURMAN WALTERS SUSAN BERKLEY 10% Owner | 0 | $0 | 7,050,000 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-01 6:40 pm | N/A 2025-09-30 | Zentalis Pharmaceuticals Inc. | ZNTL | Bucher James B Chief Legal Officer | 400,000 | $0 | 400,000 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-18 4:19 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Walker Luke Nathaniel Director | 57,603 | $0 | 144,284 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-18 4:17 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Skvarka Jan Director | 57,603 | $0 | 207,154 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-18 4:15 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Johnson David Michael Director | 57,603 | $0 | 250,421 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-18 4:14 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Kariuki Enoch Director | 57,603 | $0 | 137,365 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-18 4:12 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Myers Scott Dunseth Director | 57,603 | $0 | 338,795 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-05 6:33 pm | N/A 2035-02-02 | Zentalis Pharmaceuticals Inc. | ZNTL | Vultaggio Vincent PAO and Interim PFO | 194,219 | $0 | 225,459 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-05 6:32 pm | N/A 2035-02-02 | Zentalis Pharmaceuticals Inc. | ZNTL | Lackner Mark Chief Scientific Officer | 460,621 | $0 | 637,570 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-05 6:31 pm | N/A 2035-02-02 | Zentalis Pharmaceuticals Inc. | ZNTL | Paul Andrea Chief Legal Officer | 1,058,755 | $0 | 1,195,498 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-05 6:30 pm | N/A 2035-02-02 | Zentalis Pharmaceuticals Inc. | ZNTL | Bruns Ingmar Chief Medical Officer | 16,629 | $0 | 33,258 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-05 6:29 pm | N/A 2035-02-02 | Zentalis Pharmaceuticals Inc. | ZNTL | EASTLAND JULIA MARIE CEO & President | 59,388 | $0 | 147,276 (Direct) | View |
| 2024-12-02 Option Award | 2024-12-03 7:02 pm | N/A 2034-12-02 | Zentalis Pharmaceuticals Inc. | ZNTL | Bruns Ingmar Chief Medical Officer | 712,650 | $0 | 712,650 (Direct) | View |
| 2024-12-02 Option Award | 2024-12-03 7:02 pm | N/A 2034-12-02 | Zentalis Pharmaceuticals Inc. | ZNTL | EASTLAND JULIA MARIE CEO & President | 3,028,800 | $0 | 3,028,800 (Direct) | View |
| 2024-11-13 Option Award | 2024-11-13 5:46 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Myers Scott Dunseth Director | 260,192 | $0 | 260,192 (Direct) | View |